|Partial Close, 8/2009 ||$1.8M|
|Venture Round, 1/2010 ||$5.9M|
|Venture Round, 9/2012 ||$5M|
|Private Equity, 6/2013 ||$5M|
|Debt, 12/2009 ||$3.85M|
|Debt, 4/2011 ||$2.2M|
Diffusion Pharmaceuticals, LLC, a clinical-stage drug-discovery and development company, engages in the commercialization of small-molecule therapeutics to treat serious or life-threatening medical conditions by increasing the amount of oxygen to hypoxic tissues. Its products include trans sodium crocetinate and trans bipolar carotenoids molecules, which are used to treat life-threatening conditions, such as trauma, cancer, stroke, cardiovascular diseases, respiratory disorders, peripheral vascular and arterial diseases, and various other conditions. Diffusion Pharmaceuticals, LLC was founded in 2001 and is based in Charlottesville, Virginia.